Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent
Kristen V. Khanna, … , Leonard Shultz, Richard B. Markham
Kristen V. Khanna, … , Leonard Shultz, Richard B. Markham
Published January 15, 2002
Citation Information: J Clin Invest. 2002;109(2):205-211. https://doi.org/10.1172/JCI13236.
View: Text | PDF
Article Article has an altmetric score of 1

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

  • Text
  • PDF
Abstract

Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.

Authors

Kristen V. Khanna, Kevin J. Whaley, Larry Zeitlin, Thomas R. Moench, Karim Mehrazar, Richard A. Cone, Zhaohao Liao, James E.K. Hildreth, Timothy E. Hoen, Leonard Shultz, Richard B. Markham

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 2005 2004 2003 2002 Total
Citations: 2 2 3 3 3 1 1 1 5 6 2 1 8 5 3 1 3 4 1 1 56
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (56)

Title and authors Publication Year
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines
Bezerra BB, Silva GP, Coelho SV, Correa IA, Souza MR, Macedo KV, Matos BM, Tanuri A, Matassoli FL, Costa LJ, Hildreth JE, Arruda LB
Antiviral Research 2022
Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV Inhibitor
Francese R, Cecone C, Costantino M, Hoti G, Bracco P, Lembo D, Trotta F
International journal of molecular sciences 2022
Ovariectomized mice and postmenopausal women exhibit analogous loss of genital epithelial integrity
NE Calla, RD Miguel, KM Aceves, H Huang, B Howitt, TL Cherpes
Tissue Barriers 2021
Cyclodextrins in Antiviral Therapeutics and Vaccines.
Braga SS, Barbosa JS, Santos NE, El-Saleh F, Paz FAA
Pharmaceutics 2021
Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts
L Dubrovsky, A Ward, SH Choi, T Pushkarsky, B Brichacek, C Vanpouille, AA Adzhubei, N Mukhamedova, D Sviridov, L Margolis, RB Jones, YI Miller, M Bukrinsky, TE Smithgall
mBio 2020
HIV, progestins, genital epithelial barrier function, and the burden of objectivity†.
Vicetti Miguel RD, Quispe Calla NE, Cherpes TL
Biology of reproduction 2020
Cyclic Oligosaccharides as Active Drugs, an Updated Review
Matencio A, Caldera F, Cecone C, López-Nicolás JM, Trotta F
Pharmaceuticals 2020
Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae
R Marlin, MT Nugeyre, N Tchitchek, M Parenti, C Lefebvre, H Hocini, F Benjelloun, C Cannou, S Nozza, N Dereuddre-Bosquet, Y Levy, F Barré-Sinoussi, G Scarlatti, RL Grand, E Menu
Frontiers in immunology 2019
The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.
Salimi H, Johnson J, Flores MG, Zhang MS, O'Malley Y, Houtman JC, Schlievert PM, Haim H
The Journal of biological chemistry 2019
Cyclodextrins: Emerging Medicines of the New Millennium.
Braga SS
Biomolecules 2019
Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice
NE Calla, RD Miguel, ME Glick, JJ Kwiek, JM Gabriel, TL Cherpes
Journal of the International AIDS Society 2018
Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection
M Parsons, RL Grand, S Kent
Viruses 2018
Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation
FL Matassoli, IC Leão, BB Bezerra, RB Pollard, D Lütjohann, JE Hildreth, LB de Arruda, DH Barouch
mSphere 2018
Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa
Maud Deruaz, Thomas Murooka, Sophina Ji, Marc Gavin, Vladimir Vrbanac, Judy Lieberman, Andrew Tager, Thorsten Mempel, Andrew Luster
JCI Insight 2017
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection
NE Calla, RD Miguel, PN Boyaka, L Hall-Stoodley, B Kaur, W Trout, SD Pavelko, TL Cherpes
Mucosal Immunology 2016
Monoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model Systems:
JT Guedon, K Luo, H Zhang, RB Markham
Journal of acquired immune deficiency syndromes (1999) 2015
HIV-1 Vaginal Transmission: Cell-Free or Cell-Associated Virus?
V Barreto-de-Souza, A Arakelyan, L Margolis, C Vanpouille
American Journal of Reproductive Immunology 2014
Nanoparticle-based drug delivery to the vagina: A review
LM Ensign, R Cone, J Hanes
Journal of Controlled Release 2014
Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected
A Kohli, A Islam, DL Moyes, C Murciano, C Shen, SJ Challacombe, JR Naglik
PloS one 2014
Cell-Associated Transmission of HIV Type 1 and Other Lentiviruses in Small-Animal Models
TR Moench
The Journal of Infectious Diseases 2014
Vaginal Microbiota and Sexually Transmitted Infections That May Influence Transmission of Cell-Associated HIV
RA Cone
The Journal of Infectious Diseases 2014
Vaginal concentrations of lactic acid potently inactivate HIV
M Aldunate, D Tyssen, A Johnson, T Zakir, S Sonza, T Moench, R Cone, G Tachedjian
Journal of Antimicrobial Chemotherapy 2013
Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape
SP Parihar, R Guler, DM Lang, H Suzuki, AD Marais, F Brombacher
PloS one 2013
Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model
H Gruell, S Bournazos, JV Ravetch, A Ploss, MC Nussenzweig, J Pietzsch
Journal of virology 2013
M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
P Selhorst, K Grupping, T Tong, ET Crooks, L Martin, G Vanham, JM Binley, KK Ariën
Retrovirology 2013
Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus
D Kolodkin-Gal, SL Hulot, B Korioth-Schmitz, RB Gombos, Y Zheng, J Owuor, MA Lifton, C Ayeni, RM Najarian, WW Yeh, M Asmal, G Zamir, NL Letvin
Journal of virology 2013
Pharmacokinetics and Pharmacodynamics in HIV Prevention; Current Status and Future Directions: A Summary of the DAIDS and BMGF Sponsored Think Tank on Pharmacokinetics (PK)/Pharmacodynamics (PD) in HIV Prevention
J Romano, A Kashuba, S Becker, J Cummins, J Turpin, FV Antiretr
AIDS Research and Human Retroviruses 2013
RNA interference for the treatment of papillomavirus disease
R Singhania, N Khairuddin, D Clarke, NA McMillan
The open virology journal 2012
Non-Specific Microbicide Product Development: Then and Now
Romano JW, Robbiani M, Doncel GF, Moench T
Current HIV research 2012
A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice
CP Neff, T Kurisu, T Ndolo, K Fox, R Akkina
PloS one 2011
Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model
CP Neff, T Ndolo, A Tandon, Y Habu, R Akkina
PloS one 2010
The Role of Lipids in Retrovirus Replication
AA Waheed, EO Freed
Viruses 2010
Finally, a macaque model for cell-associated SIV/HIV vaginal transmission
DJ Anderson
The Journal of Infectious Diseases 2010
Subcellular targeting strategies for drug design and delivery
L Rajendran, HJ Knölker, K Simons
Nature Reviews Drug Discovery 2010
Preventing mucosal HIV transmission with topical microbicides – challenges and opportunities
F Hladik, GF Doncel
Antiviral Research 2010
Targeting Trojan Horse leukocytes for HIV prevention:
DJ Anderson, JA Politch, AM Nadolski, CD Blaskewicz, J Pudney, KH Mayer
AIDS 2010
Novel approaches to inhibiting HIV-1 replication
CS Adamson, EO Freed
Antiviral Research 2010
Phosphorothioate 2′ Deoxyribose Oligomers as Microbicides That Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Block Toll-Like Receptor 7 (TLR7) and TLR9 Triggering by HIV-1
JA Fraietta, YM Mueller, DH Do, VM Holmes, MK Howett, MG Lewis, AC Boesteanu, SS Alkan, PD Katsikis
Antimicrobial agents and chemotherapy 2010
HIV infection of the genital mucosa in women
F Hladik, TJ Hope
Current HIV/AIDS Reports 2009
Depletion of CD4+ T Cells in Semen During HIV Infection and Their Restoration Following Antiretroviral Therapy:
JA Politch, KH Mayer, DJ Anderson
Journal of acquired immune deficiency syndromes (1999) 2009
Lipids and membrane microdomains in HIV-1 replication
AA Waheed, EO Freed
Virus Research 2009
Glycosphingolipid Composition of Human Immunodeficiency Virus Type 1 (HIV-1) Particles Is a Crucial Determinant for Dendritic Cell-Mediated HIV-1 trans-Infection
SC Hatch, J Archer, S Gummuluru
Journal of virology 2009
Novel humanized mouse models for HIV research
Denton PW, Garcia JV
Current HIV/AIDS Reports 2009
Setting the stage: host invasion by HIV
F Hladik, MJ McElrath
Nature Reviews Immunology 2008
Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2−/−γc−/− (RAG-hu) mice
BK Berges, SR Akkina, JM Folkvord, E Connick, R Akkina
Virology 2008
Incomplete Protection against Simian Immunodeficiency Virus Vaginal Transmission in Rhesus Macaques by a Topical Antiviral Agent Revealed by Repeat Challenges
Z Ambrose, L Compton, M Piatak, D Lu, WG Alvord, MS Lubomirski, JE Hildreth, JD Lifson, CJ Miller, VN KewalRamani
Journal of virology 2008
How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?
K Gupta, PJ Klasse
PLoS Medicine 2006
Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells
P Goluszko, B Nowicki
Infection and immunity 2005
Glycolipid Transfer Protein Interaction with Bilayer Vesicles: Modulation by Changing Lipid Composition
CS Rao, T Chung, HM Pike, RE Brown
Biophysical Journal 2005
Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model
SS Olmsted, KV Khanna, EM Ng, ST Whitten, ON Johnson, RB Markham, RA Cone, TR Moench
BMC Infectious Diseases 2005
In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission
CS Dezzutti, VN James, A Ramos, ST Sullivan, A Siddig, TJ Bush, LA Grohskopf, L Paxton, S Subbarao, CE Hart
Antimicrobial agents and chemotherapy 2004
The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity
S Campbell, K Gaus, R Bittman, W Jessup, S Crowe, J Mak
Journal of virology 2004
Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis
C Gómez-Moutón, RA Lacalle, E Mira, S Jiménez-Baranda, DF Barber, AC Carrera, C Martínez-A, S Mañes
The Journal of Cell Biology 2004
Assembly and budding of influenza virus
DP Nayak, EK Hui, S Barman
Virus Research 2004
Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus with β-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts
DR Graham, E Chertova, JM Hilburn, LO Arthur, JE Hildreth
Journal of virology 2003
Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains
GD Real, S Jiménez-Baranda, RA Lacalle, E Mira, P Lucas, C Gómez-Moutón, AC Carrera, C Martínez-A, S Mañes
Journal of Experimental Medicine 2002

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
13 readers on Mendeley
See more details